Physician profile
Chad E Sundquist
NPI 1023199221
$2,908.21
in general payments reported to CMS, 2019-2025
34 companies · $570 in 2025
The $570 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $624 · 2022: $537 · 2023: $494 · 2024: $683 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $507.92 | 2021-2024 | Erleada, Akeega |
| Abbvie INC. | $398.74 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $274.16 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $197.12 | 2021-2022 | |
| Boston Scientific Corporation | $181.23 | 2022-2025 | Spaceoar Vue System - 10ml, Advantage System, Lithovue |
| Coloplast Corp | $176.50 | 2021-2025 | Speedicath |
| Dendreon Pharmaceuticals LLC | $135.20 | 2021-2022 | |
| 180 Medical, INC. | $127.14 | 2021-2024 | Gentlecath Glide |
| Ferring Pharmaceuticals INC. | $80.47 | 2025 | Adstiladrin |
| Antares Pharma, INC. | $74.82 | 2022 | |
| Merck Sharp & Dohme LLC | $73.58 | 2021-2023 | Keytruda, Lynparza |
| Myovant Sciences INC. | $71.24 | 2021-2022 | |
| Axonics, INC. | $54.70 | 2022-2024 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $49.12 | 2022-2024 | Aveed, Xiaflex |
| Teleflex LLC | $44.30 | 2023-2024 | Urolift |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $41.37 | 2024-2025 | Aquabeam System |
| Olympus America INC. | $40.32 | 2025 | Itind System |
| Urovant Sciences INC | $33.69 | 2022 | |
| Urogen Pharma, INC. | $33.56 | 2025 | |
| Endo USA, INC. | $33.01 | 2024-2025 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $30.57 | 2023 | |
| Hollister Incorporated | $29.10 | 2023 | Vapro, Infyna Chic, Vapro Pocket |
| Sagent Pharmaceuticals | $26.12 | 2024 | Glydo |
| Rochester Medical Corporation | $24.81 | 2022 | |
| Tolmar, INC. | $24.45 | 2024 | |
| Becton, Dickinson and Company | $24.25 | 2024 | |
| Palette Life Sciences, INC. | $19.07 | 2022 | |
| Davol INC. | $17.13 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $16.95 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.81 | 2021 | |
| Ambu INC. | $15.37 | 2024 | |
| Profound Medical Corp. | $12.11 | 2022 | |
| Allergan, INC. | $11.93 | 2022 | |
| Myriad Genetic Laboratories, INC. | $11.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Sundquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.